Latest Breaking News On - ஜநரல் இன்டர்னிஸ்ட் - Page 1 : comparemela.com

Making Your Health & Wellbeing a Top Priority

Dr. Elisha Brownfield This week Bobbi Conner talks with Dr. Elisha Brownfield about making your health and wellbeing a top priority, and addressing new health concerns and chronic health issues, that may have been overlooked during the pandemic. Dr. Brownfield is an Associate Professor and a General Internist at MUSC.

Bobbi connerElisha brownfieldAssociate professorGeneral internistபாபி கோனர்எலிஷா பிரவுன்ஃபீல்ட்இணை ப்ரொஃபெஸர்ஜநரல் இன்டர்னிஸ்ட்

Making Your Health & Wellbeing a Top Priority

Making Your Health & Wellbeing a Top Priority
southcarolinapublicradio.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from southcarolinapublicradio.org Daily Mail and Mail on Sunday newspapers.

Bobbi connerElisha brownfieldAssociate professorGeneral internistபாபி கோனர்எலிஷா பிரவுன்ஃபீல்ட்இணை ப்ரொஃபெஸர்ஜநரல் இன்டர்னிஸ்ட்

Adam Silverman, Author at MedCity News

Adam Silverman Adam Silverman MD is the chief medical officer of Syllable. He is a passionate healthcare innovator with 30 years of experience as a physician and executive. He has a diverse work history that includes private practice, academic medicine and physician leadership in both hospital and ambulatory settings. He is a board-certified General Internist who relocated to the West Coast in 2019 to serve as the inaugural Chief Medical Officer of Syllable. He has deep accountable and value-based care, and digital health experience and has had senior leadership roles in large health systems.

Adam silvermanGeneral internistWest coastChief medical officerWeight lossMedical devicesHealthcare innovationMedcity newsMedcity newsSan franciscoLife sciencesRock healthStartup adviceStartup fundingPatient monitoring systemOtion sensors

Clinical trials of new treatments for COVID-19 often do not include vulnerable populations

Clinical trials of new treatments for COVID-19 often do not include vulnerable populations Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by University of Chicago Medicine researchers. The findings, based on an analysis of all US COVID-19 treatment trials registered on ClinicalTrials.gov, were published Jan. 27 in the Journal of General Internal Medicine. This study highlights the blind spot in how clinical trials are done in the United States. Researchers, hospitals and pharmaceutical companies need to think hard about their commitment to improving the health of all people.

United statesAnna volermanSukarn chokkaraNeda laiteerapongSiddhi rameshEmily hendersonAmerican communityUniversity of chicagoUniversity of chicago pritzker school medicineUniversity of chicago medicineChronic disease researchChicago medicineGeneral internalSenior authorGeneral internistAssociate director